The role of N-acetylcysteine and glutathione in the management of Parkinson's disease: a systematic review of oxidative biomarkers and clinical outcomes.
- 2026-03-24
- Systematic Review · n = 196
- Amino acids 58(1)
- Imran Mohammed
- Yasimin Nankya
- U Teng Hong
- Amy Kan
- Alya Masoud Abdelhafid
- Gladys O Latunde-Dada
- PubMed: 41874704
- DOI: 10.1007/s00726-026-03513-5
- High evidence
- Clinical
NAC improved both motor and non-motor symptoms and significantly increased GSH/GSSG ratios, GSH levels in the CSF, and DAT binding.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- No